| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| CorMedix Inc. | EVP, Head of Clinical Ops. | Common Stock | 45.4K | $158K | $3.47 | Jan 12, 2024 | Direct |
| CorMedix Inc. | EVP, Head of Clinical Ops. | Stock Option (Right to Buy Common Stock) | 100K | Jan 12, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| CRMD | CorMedix Inc. | Jan 12, 2024 | 0 | $0 | 4/A | Jan 18, 2024 | EVP, Head of Clinical Ops. |
| CRMD | CorMedix Inc. | Jan 12, 2024 | 3 | -$16K | 4 | Jan 17, 2024 | EVP, Head of Clinical Ops. |
| CRMD | CorMedix Inc. | Jan 14, 2023 | 1 | $0 | 4 | Jan 18, 2023 | EVP, Head of Clinical Ops. |
| CRMD | CorMedix Inc. | Feb 18, 2022 | 1 | $0 | 4 | Feb 23, 2022 | EVP, Head of Clinical Ops. |
| CRMD | CorMedix Inc. | May 21, 2021 | 1 | -$55.4K | 4 | May 25, 2021 | EVP, Head of Clinical Ops |